Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
| Date | Insider | Title | Type | Price | Shares | Value | Owned After |
|---|---|---|---|---|---|---|---|
| Sep 7, 26 | Nicholson Nur | CTO | Purchase | $16.23 | 220.00K | $3.57M | 220.00K |
| Aug 31, 26 | Nicholson Nur | -- | Sale | -- | -- | -- | -- |
| Jul 6, 26 | Tregoning Kathleen | Officer | Purchase | $23.30 | 175.00K | $4.08M | 175.00K |
| Jun 29, 26 | Tregoning Kathleen | -- | Sale | -- | -- | -- | -- |
| Jun 9, 26 | Renaud Ronald C JR | CEO | Sale | $5.25 | 38.09K | $199.99K | 817.83K |
| Jun 9, 26 | Renaud Ronald C JR | CEO | Purchase | $5.25 | 38.09K | $199.99K | 38.09K |
| Apr 20, 26 | RTW INVESTMENTS, LP | 10 percent owner | Purchase | $16.00 | 500.00K | $8.00M | 10.78M |
| Apr 20, 26 | RTW INVESTMENTS, LP | 10 percent owner | Purchase | -- | 10.28M | -- | 10.28M |
| Apr 20, 26 | RTW INVESTMENTS, LP | 10 percent owner | Sale | -- | 8.25M | -- | -- |
| Apr 20, 26 | RTW INVESTMENTS, LP | 10 percent owner | Sale | -- | 2.03M | -- | -- |
| Apr 20, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Purchase | -- | 9.48M | -- | 9.48M |
| Apr 20, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Purchase | -- | 2.03M | -- | 2.03M |
| Apr 20, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Sale | -- | 4.97M | -- | -- |
| Apr 20, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Sale | -- | 708.81K | -- | -- |
| Apr 20, 26 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | Purchase | $16.00 | 8.40M | $134.38M | 26.26M |
| Apr 20, 26 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | Purchase | -- | 17.86M | -- | 17.86M |
| Apr 20, 26 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | Sale | -- | 17.86M | -- | -- |
| Apr 20, 26 | Koppel Adam | CTO | Purchase | $16.00 | 1.56M | $25.00M | 22.58M |
| Apr 20, 26 | Koppel Adam | CTO | Purchase | -- | 4.15M | -- | 21.02M |
| Apr 20, 26 | Koppel Adam | CTO | Purchase | -- | 16.88M | -- | 16.88M |
| Apr 16, 26 | Koppel Adam | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 20, 26 | Koppel Adam | CTO | Sale | -- | 16.88M | -- | -- |
| Apr 20, 26 | Koppel Adam | CTO | Sale | -- | 4.15M | -- | -- |
| Apr 20, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Purchase | $16.00 | 1.56M | $25.00M | 22.58M |
| Apr 20, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Purchase | -- | 4.15M | -- | 21.02M |
| Apr 20, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Purchase | -- | 16.88M | -- | 16.88M |
| Apr 20, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sale | -- | 16.88M | -- | -- |
| Apr 20, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sale | -- | 4.15M | -- | -- |
| Apr 20, 26 | Kaplan Andrew T. | CTO | Purchase | $16.00 | 8.40M | $134.38M | 26.26M |
| Apr 20, 26 | Kaplan Andrew T. | CTO | Purchase | -- | 17.86M | -- | 17.86M |
| Apr 16, 26 | Kaplan Andrew T. | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 20, 26 | Kaplan Andrew T. | CTO | Sale | -- | 17.86M | -- | -- |
| Apr 16, 26 | Cloghessy Paula | Officer | Purchase | $16.00 | 60.00K | $960.00K | 60.00K |
| Apr 16, 26 | Akamine Scott | Officer | Purchase | $16.00 | 60.00K | $960.00K | 60.00K |
| Apr 16, 26 | Renaud Ronald C JR | CEO | Purchase | $16.00 | 300.00K | $4.80M | 300.00K |
| Apr 16, 26 | Burgess Paul D. | Officer | Purchase | $16.00 | 100.00K | $1.60M | 100.00K |
| Apr 16, 26 | MILLIGAN JOHN F | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 16, 26 | Coleman Jamie Beth | Officer | Purchase | $16.00 | 75.00K | $1.20M | 75.00K |
| Apr 16, 26 | MACKAY MARTIN | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 16, 26 | Wasserman Scott M. | Officer | Purchase | $16.00 | 100.00K | $1.60M | 100.00K |
| Apr 16, 26 | Hite Christopher | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 16, 26 | Clyburn Frank | CTO | Purchase | $16.00 | 38.30K | $612.80K | 38.30K |
| Apr 16, 26 | Pagan Douglas W. | CFO | Purchase | $16.00 | 100.00K | $1.60M | 100.00K |
| Apr 16, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Sale | -- | -- | -- | 1 |
| Apr 16, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Sale | -- | 9.48M | -- | -- |
| Apr 16, 26 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | Sale | -- | 2.03M | -- | -- |
| Apr 16, 26 | Koppel Adam | CTO | Sale | -- | 16.88M | -- | -- |
| Apr 16, 26 | Koppel Adam | CTO | Sale | -- | 4.15M | -- | -- |
| Apr 16, 26 | BAIN CAPITAL INVESTORS LLC | 10 percent owner | Sale | -- | 17.86M | -- | -- |
| Apr 16, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sale | -- | 16.88M | -- | -- |
| Apr 16, 26 | Bain Capital Life Sciences Investors, LLC | 10 percent owner | Sale | -- | 4.15M | -- | -- |
| Apr 16, 26 | Kaplan Andrew T. | CTO | Sale | -- | 17.86M | -- | -- |
| Apr 16, 26 | Burgess Paul D. | Officer | Sale | $5.25 | 191.44K | $1.01M | -- |
| Apr 16, 26 | Burgess Paul D. | Officer | Sale | $7.24 | 325.49K | $2.36M | -- |
| Apr 16, 26 | Wasserman Scott M. | Officer | Sale | $5.25 | 427.96K | $2.25M | -- |
| Apr 16, 26 | Wasserman Scott M. | Officer | Sale | $7.24 | 147.32K | $1.07M | -- |
| Apr 16, 26 | Pagan Douglas W. | CFO | Sale | $10.09 | 700.80K | $7.07M | -- |
| Apr 16, 26 | Coleman Jamie Beth | Officer | Sale | $5.40 | 357.56K | $1.93M | -- |
| Apr 16, 26 | Coleman Jamie Beth | Officer | Sale | $7.24 | 268.33K | $1.94M | -- |
| Apr 16, 26 | RTW INVESTMENTS, LP | 10 percent owner | Sale | -- | 8.25M | -- | -- |
| Apr 16, 26 | RTW INVESTMENTS, LP | 10 percent owner | Sale | -- | 2.03M | -- | -- |
| Apr 16, 26 | MACKAY MARTIN | CTO | Sale | $11.56 | 170.19K | $1.97M | -- |
| Apr 16, 26 | Liu Yuting | -- | Sale | -- | -- | -- | -- |
| Apr 16, 26 | Hite Christopher | CTO | Sale | $5.40 | 81.05K | $437.66K | -- |
| Apr 16, 26 | Hite Christopher | CTO | Sale | $7.24 | 89.15K | $645.42K | -- |
| Apr 16, 26 | Cloghessy Paula | Officer | Sale | $5.25 | 86.15K | $452.29K | -- |
| Apr 16, 26 | Cloghessy Paula | Officer | Sale | $5.40 | 95.35K | $514.89K | -- |
| Apr 16, 26 | Cloghessy Paula | Officer | Sale | $7.24 | 230.73K | $1.67M | -- |
| Apr 16, 26 | Renaud Ronald C JR | CEO | Sale | $5.25 | 287.17K | $1.51M | -- |
| Apr 16, 26 | Renaud Ronald C JR | CEO | Sale | $7.24 | 1.33M | $9.64M | -- |
| Apr 16, 26 | Clyburn Frank | CTO | Sale | $7.24 | 170.19K | $1.23M | -- |
| Apr 16, 26 | Akamine Scott | Officer | Sale | $5.25 | 143.67K | $754.28K | -- |
| Apr 16, 26 | Akamine Scott | Officer | Sale | $7.24 | 194.00K | $1.40M | -- |
| Apr 16, 26 | MILLIGAN JOHN F | CTO | Sale | $5.25 | 285.31K | $1.50M | -- |
| Apr 16, 26 | MILLIGAN JOHN F | CTO | Sale | $7.24 | 313.82K | $2.27M | -- |
| Apr 16, 26 | CANADA PENSION PLAN INVESTMENT BOARD | 10 percent owner | Sale | -- | 5.00M | -- | -- |
| Apr 16, 26 | Stuart Partners, LLC | 10 percent owner | Sale | -- | 1.43M | -- | -- |
Latest filing Checked hourly; insiders must file within 2 business days of a tradeAbout this data
